Formalin Fixed Paraffin Embedded Tissue Articles & Analysis
12 news found
These primary antibody products have successfully been stained on formalin-fixed and paraffin-embedded (FFPE) tissue sections. Meanwhile, each product is manufactured to high standards and fully validated in immunohistochemistry. ...
Through this collaborative partnership, xCures and mProbe will work toward helping cancer patients better understand their tumors’ molecular profile at the proteomic level, allowing precision diagnostics to guide precision medicines by selecting the most effective cancer treatment regimens. mProbe uses a pathologist guided laser microdissection platform to isolate tumor areas from ...
ByxCures
--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and blood-based assays as companion diagnostics for RETEVMO® and other therapies in Loxo Oncology at Lilly’s pipeline. ...
About FoundationOne CDx FoundationOne CDx is a next-generation sequencing based in vitro diagnostic device for detection of substitutions, insertion and deletion alterations (indels), and copy number alterations (CNAs) in 324 genes and select gene rearrangements, as well as genomic signatures including microsatellite instability (MSI) and tumor mutational burden (TMB) using DNA isolated from ...
Under the new agreements, TRICARE beneficiaries now have improved access to Foundation Medicine’s FDA-approved comprehensive genomic profiling (CGP) tests, FoundationOne®CDx and FoundationOne®Liquid CDx, in accordance with their approved indications for all solid tumors. Through tissue or blood samples, FoundationOne CDx and FoundationOne Liquid CDx evaluate more ...
"The FDA's approval of Oncomine Dx Target Test enables clinicians to use FFPE tissue samples to identify patients in the U.S. who may benefit from this important new therapy," said Garret Hampton, president, clinical next-generation sequencing and oncology at Thermo Fisher Scientific. ...
The Oncomine Precision Assay, which is designed to detect key biomarkers from formalin-fixed paraffin-embedded (FFPE) tissue and liquid biopsy specimens, contains more than 50 cancer-related biomarkers and has the lowest sample input requirements on the market for detection of both DNA and RNA variants. ...
The Oncomine Precision Assay can detect more than 50 cancer-related biomarkers from formalin-fixed paraffin-embedded (FFPE) tumor tissues or liquid biopsy specimens. ...
The Oncomine Precision Assay is a next-generation sequencing (NGS) assay that is used to detect key biomarkers from formalin-fixed paraffin-embedded (FFPE) tissue or liquid biopsy specimen. ...
Collection of fresh-frozen tumor samples is often challenging or infeasible, leading many studies to rely on formalin-fixed, paraffin-embedded (FFPE) tumor tissue samples. Because these tissues are often paired with a great deal of clinical and outcome data, analysis of these archives has the ...
Cohen, BS, CG(ASCP)CM and Sharon Alsobrook, CG(ASCP)CM, MLS(ASCP)CM, is based on ProPath's comprehensive, eight-month study of 1,500 formalin-fixed, paraffin-embedded tissue sections. The white paper highlights the major advantages customers experience by using Dako's HER2 IQFISH pharmDx kit, which uses the ...
(NYSE: A) today introduced the IQFISH FFPE Hybridization buffer, which enables one-hour hybridization for FISH processing on formalin fixed paraffin embedded (FFPE) tissue samples. The IQ technology, originally developed by Dako, was previously available only to anatomic pathology labs. ...